Answer:
Ion i think
Explanation:
I think ion's contain more negative energy from electrons and since it's -18 and 9+ it would be -9 if u add them up
Answer:
b) The nuclear envelope is continuous with the Golgi apparatus.
Explanation:
The nuclear envelope is a nuclear membrane composed of two lipid bilayers: inner and outer membrane and perinuclear space between them. Its outer membrane is continuous with the endoplasmic reticulum. Nuclear pores that are part of this envelope allow the movement of molecules in and from the nucleus (e.g. mRNA formed during transcription should be transported into cytosol through the pores).
<span>In biological terms, the structure of a species is usually best adapted to give it the most advantageous functional ability, though this is not always the case. When a structure has a function that allows the species to survive and promulgate its genetic structure, the individual will be more likely to reproduce its genotype over those that are not structurally advantageous.</span>
<h2>Issues with animal research in bred</h2>
Explanation:
- Since all animals are reared and brought up in a similar domain, they may contrast from animals reproduced in an alternate settlement Animal activist may think that its unscrupulous to utilize animals in look into Working with animals requires IRB conventions that protect the prosperity of the animals, making it difficult to play out certain examinations on them.
- Scientific researchers keep up that despite the fact that animal research, (as some other models in vitro or on the other hand human), doesn't generally convey ideal outcomes for human pertinence, it's still – in blend with important non-creature techniques - the essential method to do research to comprehend living systems and to give the most ideal affirmation of the impacts of new medicines preceding the primary clinical preliminaries in people.
- Clinical preliminaries are not ready to give results with 100% precision because of the huge inconstancy of the human population. The medicines improvement process including in silico, in vitro, pre-clinical (animals) and clinical (human) stages diminish the hazard for the Human population as a whole.
